Month of birth linked to risk of MS

December 06, 2004

In the northern hemisphere, being born in May is linked to an increased risk of developing multiple sclerosis later in life, while being born in November carries the lowest risk, finds a new study published on today.

The researchers suspect that complex interactions between genes and the environment before or shortly after birth may help to explain this link.

Their study involved 17,874 Canadian patients and 11,502 British patients with multiple sclerosis. Data on month of birth, along with detailed information on demographics and medical and family history, were collected and analysed. The comparison groups were both from the general population and from the unaffected brothers and sisters of those with MS.

In Canada, significantly fewer people with MS were born in November compared with controls. Similarly in Britain, fewer people with MS had been born in November and significantly more had been born in May. The number born in December was also significantly lower.

Adding Danish and Swedish samples to the Canadian and British results (over 42,000 people) showed a 13% increase in risk of MS for those born in May compared with November and a 19% decreased risk for those born in November compared with May.

The effect was most evident in Scotland, where the prevalence of MS is the highest.

These findings conclusively show the association between month of birth and risk of MS in northern countries, but the explanation remains unclear, say the authors.

Previous studies have suggested that exposure to the sun or seasonal variations in a mother's vitamin D levels during pregnancy may have an impact on brain development.

These findings support suggestions that environmental factors both before and immediately after birth may influence the development of the nervous or immune systems and therefore determine the risk for this disease in adult life, they conclude.


Related Multiple Sclerosis Articles from Brightsurf:

New therapy improves treatment for multiple sclerosis
A new therapy that binds a cytokine to a blood protein shows potential in treating multiple sclerosis, and may even prevent it.

'Reelin' in a new treatment for multiple sclerosis
In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease's characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Not all multiple sclerosis-like diseases are alike
Scientists say some myelin-damaging disorders have a distinctive pathology that groups them into a unique disease entity.

New therapeutic options for multiple sclerosis in sight
Strategies for treating multiple sclerosis have so far focused primarily on T and B cells.

Diet has an impact on the multiple sclerosis disease course
The short-chain fatty acid propionic acid influences the intestine-mediated immune regulation in people with multiple sclerosis (MS).

The gut may be involved in the development of multiple sclerosis
It is incompletely understood which factors in patients with multiple sclerosis act as a trigger for the immune system to attack the brain and spinal cord.

Slowing the progression of multiple sclerosis
Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown.

7T MRI offers new insights into multiple sclerosis
Investigators from Brigham and Women's Hospital have completed a new study using 7 Tesla (7T) MRI -- a far more powerful imaging technology -- to further examine LME in MS patients

How to improve multiple sclerosis therapy
Medications currently used to treat multiple sclerosis (MS) can merely reduce relapses during the initial relapsing-remitting phase.

Vaccinations not a risk factor for multiple sclerosis
Data from over 12,000 multiple sclerosis (MS) patients formed the basis of a study by the Technical University of Munich (TUM) which investigated the population's vaccination behavior in relation to MS.

Read More: Multiple Sclerosis News and Multiple Sclerosis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to